×

Akorn to Present at the 33rd Annual J.P. Morgan Healthcare Conference

LAKE FOREST, Ill., Dec. 19, 2014 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a specialty generic pharmaceutical company, announced today that Raj Rai, Chief Executive Officer, will provide an overview and update of the Company's business at the 33rd Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2015 at 4:00 pm PST (7:00 pm EST) at the Westin St. Francis Hotel, San Francisco, California. Mr. Rai's presentation to investors will be webcast and available to interested investors and analysts.

To access the webcast and replay, go to the Akorn Investor Relations Website at http://investors.akorn.com. The webcast can also be accessed by following the below URL:

http://jpmorgan.metameetings.com/confbook/healthcare15/directlink?p=16808

An archived version of Mr. Rai's comments will be available approximately one hour after the live presentation ends and can be accessed at the same locations for 90 days following the presentation.

About Akorn, Inc.

Akorn, Inc. is a specialty pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. Akorn has manufacturing facilities located in Decatur, Illinois; Somerset, New Jersey; Amityville, New York and Paonta Sahib, India where the Company manufactures ophthalmic, injectable and specialty non-sterile pharmaceuticals. Additional information is available on the Company's website at www.akorn.com.

CONTACT: Investors/Media: Dewey Steadman Executive Director, Investor Relations (847) 582-6923 investor.relations@akorn.com

Source:Akorn, Inc.